Back
Arbutus Biopharma Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
ABUS
Arbutus Biopharma
Last Price:
3.50
Seasonality Move:
15.21%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Arbutus Biopharma Stock Forecast
-
Is Arbutus Biopharma Stock Undervalued?
The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal. - ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Arbutus Biopharma Stock Go Up Next Year?
Data Unavailable
Arbutus Biopharma Stock Rating
Data Unavailable
Arbutus Biopharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arbutusbio.com
52-Week Data
52-Week High:
4.73
52-Week Low:
1.79
Prediction Charts
Market Cap:
651.85M
Price in USD:
3.44
Volume:
626.37K
Beta:
1.21
Technical Analysis
SMA50:
3.93
SMA100:
3.84
SMA200:
3.37
52-Wk Change:
86.96%
Stock Predictions
-
Is Arbutus Biopharma stock public?
Yes, Arbutus Biopharma is a publicly traded company. -
What is the Arbutus Biopharma stock quote today?
The Arbutus Biopharma stock price is 3.44 USD today. -
How to buy Arbutus Biopharma stock online?
You can buy Arbutus Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 3.85 | 3.96 | 3.99 | 3.80 |
| Nov-4 | 3.96 | 3.86 | 3.96 | 3.86 |
| Nov-5 | 3.86 | 3.96 | 3.96 | 3.80 |
| Nov-6 | 3.85 | 3.92 | 3.96 | 3.60 |
| Nov-7 | 3.92 | 3.73 | 3.92 | 3.70 |
| Nov-8 | 3.75 | 3.75 | 3.79 | 3.70 |
| Nov-11 | 3.75 | 3.74 | 3.84 | 3.73 |
| Nov-12 | 3.73 | 3.65 | 3.75 | 3.61 |
| Nov-13 | 3.65 | 3.65 | 3.76 | 3.65 |
| Nov-14 | 3.66 | 3.63 | 3.81 | 3.63 |
| Nov-15 | 3.68 | 3.64 | 3.68 | 3.42 |
| Nov-18 | 3.64 | 3.52 | 3.68 | 3.49 |
| Nov-19 | 3.51 | 3.49 | 3.52 | 3.42 |
| Nov-20 | 3.53 | 3.44 | 3.54 | 3.42 |
Arbutus Biopharma Earnings
Data Unavailable
Arbutus Biopharma Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.